{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:39Z","timestamp":1789685019603,"version":"4.0.1"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"1","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mechanisms of action of nonmutagenic carcinogens such as asbestos remain poorly characterized. As pleural mesothelioma is known to have limited numbers of genetic mutations, we aimed to characterize the relationships among gene-locus\u2013specific methylation alterations, disease status, asbestos burden, and survival in this rapidly fatal asbestos-associated tumor. Methylation of 1505 CpG loci associated with 803 cancer-related genes were studied in 158 pleural mesotheliomas and 18 normal pleura. After false-discovery rate correction, 969 CpG loci were independently associated with disease status (Q &amp;lt; 0.05). Classifying samples based on CpG methylation profile with a mixture model approach, methylation classes discriminated tumor from normal pleura (permutation P &amp;lt; 0.0001). In a random forests classification, the overall misclassification error rate was 3.4%, with &amp;lt;1% (n = 1) of tumors misclassified as normal (P &amp;lt; 0.0001). Among tumors, methylation class membership was significantly associated with lung tissue asbestos body burden (P &amp;lt; 0.03), and significantly predicted survival (likelihood ratio P &amp;lt; 0.01). Consistent with prior work, asbestos burden was associated with an increased risk of death (hazard ratio, 1.4; 95% confidence interval, 1.1\u20131.8). Our results have shown that methylation profiles powerfully differentiate diseased pleura from nontumor pleura and that asbestos burden and methylation profiles are independent predictors of mesothelioma patient survival. We have added to the growing body of evidence that cellular epigenetic dysregulation is a critical mode of action for asbestos in the induction of pleural mesothelioma. Importantly, these findings hold great promise for using epigenetic profiling in the diagnosis and prognosis of human cancers. [Cancer Res 2009;69(1):227\u201334]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-2586","type":"journal-article","created":{"date-parts":[[2008,12,31]],"date-time":"2008-12-31T03:22:49Z","timestamp":1230693769000},"page":"227-234","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":133,"title":["Epigenetic Profiles Distinguish Pleural Mesothelioma from Normal Pleura and Predict Lung Asbestos Burden and Clinical Outcome"],"prefix":"10.1158","volume":"69","author":[{"given":"Brock C.","family":"Christensen","sequence":"first","affiliation":[{"name":"1Community Health, Center for Environmental Health and Technology and Departments of"},{"name":"2Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.A.","family":"Houseman","sequence":"additional","affiliation":[{"name":"3Department of Work Environment, University of Massachusetts Lowell, Lowell, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Godleski","sequence":"additional","affiliation":[{"name":"4Department of Environmental Health, Harvard School of Public Health,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen J.","family":"Marsit","sequence":"additional","affiliation":[{"name":"2Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Longacker","sequence":"additional","affiliation":[{"name":"5Department of Environmental Health, Boston University School of Public Health, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora R.","family":"Roelofs","sequence":"additional","affiliation":[{"name":"3Department of Work Environment, University of Massachusetts Lowell, Lowell, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Karagas","sequence":"additional","affiliation":[{"name":"7Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire; Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret R.","family":"Wrensch","sequence":"additional","affiliation":[{"name":"8Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Fang","family":"Yeh","sequence":"additional","affiliation":[{"name":"9Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather H.","family":"Nelson","sequence":"additional","affiliation":[{"name":"10Division of Epidemiology and Community Health, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe L.","family":"Wiemels","sequence":"additional","affiliation":[{"name":"9Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichun","family":"Zheng","sequence":"additional","affiliation":[{"name":"8Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Wiencke","sequence":"additional","affiliation":[{"name":"8Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[{"name":"6Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sugarbaker","sequence":"additional","affiliation":[{"name":"6Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl T.","family":"Kelsey","sequence":"additional","affiliation":[{"name":"1Community Health, Center for Environmental Health and Technology and Departments of"},{"name":"2Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,12,31]]},"reference":[{"key":"2022061700284158200_B1","doi-asserted-by":"crossref","unstructured":"Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell\u20081990; 61: 759\u201367.","DOI":"10.1016\/0092-8674(90)90186-I"},{"key":"2022061700284158200_B2","unstructured":"Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res\u20081991; 51: 3075\u20139."},{"key":"2022061700284158200_B3","doi-asserted-by":"crossref","unstructured":"Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev\u20082002; 3: 415\u201328.","DOI":"10.1038\/nrg816"},{"key":"2022061700284158200_B4","doi-asserted-by":"crossref","unstructured":"Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res\u20082006; 16: 383\u201393.","DOI":"10.1101\/gr.4410706"},{"key":"2022061700284158200_B5","doi-asserted-by":"crossref","unstructured":"Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med\u20082005; 353: 1591\u2013603.","DOI":"10.1056\/NEJMra050152"},{"key":"2022061700284158200_B6","doi-asserted-by":"crossref","unstructured":"Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y. Asbestos-related lung cancer and mesothelioma in Japan. Ind Health\u20082001; 39: 65\u201374.","DOI":"10.2486\/indhealth.39.65"},{"key":"2022061700284158200_B7","doi-asserted-by":"crossref","unstructured":"Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol\u20082004; 159: 107\u201312.","DOI":"10.1093\/aje\/kwh025"},{"key":"2022061700284158200_B8","doi-asserted-by":"crossref","unstructured":"Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet\u20082001; 357: 444\u20135.","DOI":"10.1016\/S0140-6736(00)04013-7"},{"key":"2022061700284158200_B9","unstructured":"Bhagavatula R, Moody R, Russ J. Asbestos: a moving target. Best's Rev\u20082001; 102: 85\u201390."},{"key":"2022061700284158200_B10","doi-asserted-by":"crossref","unstructured":"Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer\u20081999; 79: 666\u201372.","DOI":"10.1038\/sj.bjc.6690105"},{"key":"2022061700284158200_B11","unstructured":"Joshi TK, Gupta RK. Asbestos in developing countries: magnitude of risk and its practical implications. Int J Occup Med Environ Health\u20082004; 17: 179\u201385."},{"key":"2022061700284158200_B12","doi-asserted-by":"crossref","unstructured":"Landrigan PJ, Lioy PJ, Thurston G, et al. Health and environmental consequences of the world trade center disaster. Environ Health Perspect\u20082004; 112: 731\u20139.","DOI":"10.1289\/ehp.6702"},{"key":"2022061700284158200_B13","doi-asserted-by":"crossref","unstructured":"Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med\u20081960; 17: 260\u201371.","DOI":"10.1136\/oem.17.4.260"},{"key":"2022061700284158200_B14","doi-asserted-by":"crossref","unstructured":"Jaurand MC. Mechanisms of fiber-induced genotoxicity. Environ Health Perspect\u20081997; 105 Suppl 5: 1073\u201384.","DOI":"10.1289\/ehp.97105s51073"},{"key":"2022061700284158200_B15","doi-asserted-by":"crossref","unstructured":"Kelsey KT, Yano E, Liber HL, Little JB. The in vitro genetic effects of fibrous erionite and crocidolite asbestos. Br J Cancer\u20081986; 54: 107\u201314.","DOI":"10.1038\/bjc.1986.158"},{"key":"2022061700284158200_B16","doi-asserted-by":"crossref","unstructured":"He B, Lee AY, Dadfarmay S, et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in \u03b2-catenin-deficient human mesothelioma cells. Cancer Res\u20082005; 65: 743\u20138.","DOI":"10.1016\/S0169-5002(05)80345-9"},{"key":"2022061700284158200_B17","doi-asserted-by":"crossref","unstructured":"Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E, Kelsey KT. Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis\u20082002; 23: 1127\u201330.","DOI":"10.1093\/carcin\/23.7.1127"},{"key":"2022061700284158200_B18","doi-asserted-by":"crossref","unstructured":"Tsou JA, Galler JS, Wali A, et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer\u20082007; 58: 220\u201330.","DOI":"10.1016\/j.lungcan.2007.06.015"},{"key":"2022061700284158200_B19","doi-asserted-by":"crossref","unstructured":"Tsou JA, Shen LY, Siegmund KD, et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer\u20082005; 47: 193\u2013204.","DOI":"10.1016\/j.lungcan.2004.08.003"},{"key":"2022061700284158200_B20","doi-asserted-by":"crossref","unstructured":"Christensen BC, Godleski JJ, Marsit CJ, et al. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis\u20082008; 29: 1555\u20139.","DOI":"10.1093\/carcin\/bgn059"},{"key":"2022061700284158200_B21","doi-asserted-by":"crossref","unstructured":"De Vuyst P, Karjalainen A, Dumortier P, et al. 1998 ERS Task Force Report Guidelines for mineral fibre analyses in biological samples: report of the ERS working group. Eur Respir J\u20081998; 11: 1416\u201326.","DOI":"10.1183\/09031936.98.11061416"},{"key":"2022061700284158200_B22","unstructured":"Churg A, Warnock ML. Correlation of quantitative asbestos body counts and occupation in urban patients. Arch Pathol Lab Med\u20081977; 101: 629\u201334."},{"key":"2022061700284158200_B23","unstructured":"R Development CT. R: A Language and Environment for Statistical Computing. Vienna (Austria): R Foundation for Statistical Computing; 2007."},{"key":"2022061700284158200_B24","doi-asserted-by":"crossref","unstructured":"Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev\u20082007; 16: 108\u201314.","DOI":"10.1158\/1055-9965.EPI-06-0636"},{"key":"2022061700284158200_B25","doi-asserted-by":"crossref","unstructured":"Storey J, Taylor J, Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: A unified approach. J Royal Stat Soc\u20082004; Series B: 187\u2013205.","DOI":"10.1111\/j.1467-9868.2004.00439.x"},{"key":"2022061700284158200_B26","doi-asserted-by":"crossref","unstructured":"Houseman EA, Christensen BC, Marsit CJ, et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of \u03b2 distributions. BMC Bioinformatics 2008;9.","DOI":"10.1186\/1471-2105-9-365"},{"key":"2022061700284158200_B27","doi-asserted-by":"crossref","unstructured":"Yao Y. Information-theoretic measures for knowledge discovery and data mining In: Karmeshu, editor. Entropy Measures, Maximum Entropy Principle and Emerging Applications: Springer; 2003. p. 115\u201336.","DOI":"10.1007\/978-3-540-36212-8_6"},{"key":"2022061700284158200_B28","doi-asserted-by":"crossref","unstructured":"Breiman L. Random Forests. Machine Learning\u20082001; 45: 5\u201332.","DOI":"10.1023\/A:1010933404324"},{"key":"2022061700284158200_B29","doi-asserted-by":"crossref","unstructured":"Shen L, Toyota M, Kondo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A\u20082007; 104: 18654\u20139.","DOI":"10.1073\/pnas.0704652104"},{"key":"2022061700284158200_B30","doi-asserted-by":"crossref","unstructured":"Siegmund KD, Connor CM, Campan M, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE\u20082007; 2: e895.","DOI":"10.1371\/journal.pone.0000895"},{"key":"2022061700284158200_B31","doi-asserted-by":"crossref","unstructured":"Siegmund KD, Laird PW, Laird-Offringa IA. A comparison of cluster analysis methods using DNA methylation data. Bioinformatics (Oxford England)\u20082004; 20: 1896\u2013904.","DOI":"10.1093\/bioinformatics\/bth176"},{"key":"2022061700284158200_B32","doi-asserted-by":"crossref","unstructured":"Christensen BC, Godleski JJ, Roelofs CR, et al. Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect\u20082008; 116: 723\u20136.","DOI":"10.1289\/ehp.11151"},{"key":"2022061700284158200_B33","doi-asserted-by":"crossref","unstructured":"Sugarbaker DJ, Richards WG, Gordon GJ, et al. Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A\u20082008; 105: 3521\u20136.","DOI":"10.1073\/pnas.0712399105"},{"key":"2022061700284158200_B34","doi-asserted-by":"crossref","unstructured":"Gordon GJ, Rockwell GN, Jensen RV, et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol\u20082005; 166: 1827\u201340.","DOI":"10.1016\/S0002-9440(10)62492-3"},{"key":"2022061700284158200_B35","doi-asserted-by":"crossref","unstructured":"Gordon GJ, Jensen RV, Hsiao LL, et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst\u20082003; 95: 598\u2013605.","DOI":"10.1093\/jnci\/95.8.598"},{"key":"2022061700284158200_B36","doi-asserted-by":"crossref","unstructured":"Gordon GJ, Rockwell GN, Godfrey PA, et al. Validation of genomics-based prognostic tests in malignant pleural mesothelioma. Clin Cancer Res\u20082005; 11: 4406\u201314.","DOI":"10.1158\/1078-0432.CCR-04-2181"},{"key":"2022061700284158200_B37","doi-asserted-by":"crossref","unstructured":"Lopez-Rios F, Chuai S, Flores R, et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res\u20082006; 66: 2970\u20139.","DOI":"10.1158\/0008-5472.CAN-05-3907"},{"key":"2022061700284158200_B38","unstructured":"Moalli PA, MacDonald JL, Goodglick LA, Kane AB. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am J Pathol\u20081987; 128: 426\u201345."},{"key":"2022061700284158200_B39","unstructured":"Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res\u20082001; 61: 3573\u20137."},{"key":"2022061700284158200_B40","doi-asserted-by":"crossref","unstructured":"Quinlan TR, Marsh JP, Janssen YM, Borm PA, Mossman BT. Oxygen radicals and asbestos-mediated disease. Environ Health Perspect\u20081994; 102 Suppl 10: 107\u201310.","DOI":"10.1289\/ehp.94102s10107"},{"key":"2022061700284158200_B41","doi-asserted-by":"crossref","unstructured":"Chen Q, Marsh J, Ames B, Mossman B. Detection of 8-oxo-2\u2032-deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos. Carcinogenesis\u20081996; 17: 2525\u20137.","DOI":"10.1093\/carcin\/17.11.2525"},{"key":"2022061700284158200_B42","doi-asserted-by":"crossref","unstructured":"Masuda T, Shinoara H, Kondo M. Reactions of hydroxyl radicals with nucleic acid bases and the related compounds in \u03b3-irradiated aqueous solution. J Radiat Res\u20081975; 16: 153\u201361.","DOI":"10.1269\/jrr.16.153"},{"key":"2022061700284158200_B43","doi-asserted-by":"crossref","unstructured":"Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res\u20082004; 32: 4100\u20138.","DOI":"10.1093\/nar\/gkh739"},{"key":"2022061700284158200_B44","doi-asserted-by":"crossref","unstructured":"Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res\u20082007; 67: 946\u201350.","DOI":"10.1158\/0008-5472.CAN-06-3123"},{"key":"2022061700284158200_B45","doi-asserted-by":"crossref","unstructured":"Henderson JP, Byun J, Takeshita J, Heinecke JW. Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J Biol Chem\u20082003; 278: 23522\u20138.","DOI":"10.1074\/jbc.M303928200"},{"key":"2022061700284158200_B46","doi-asserted-by":"crossref","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell\u20082000; 100: 57\u201370.","DOI":"10.1016\/S0092-8674(00)81683-9"},{"key":"2022061700284158200_B47","doi-asserted-by":"crossref","unstructured":"Li JY, Chai BX, Zhang W, Liu YQ, Ammori JB, Mulholland MW. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity. Cell Signal\u20082007; 19: 1185\u201392.","DOI":"10.1016\/j.cellsig.2006.12.010"},{"key":"2022061700284158200_B48","doi-asserted-by":"crossref","unstructured":"Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol\u20082007; 7: 454\u201365.","DOI":"10.1038\/nri2093"},{"key":"2022061700284158200_B49","doi-asserted-by":"crossref","unstructured":"Trivedi CM, Patel RC, Patel CV. Homeobox gene HOXA9 inhibits nuclear factor-\u03ba B dependent activation of endothelium. Atherosclerosis\u20082007; 195: e50\u201360.","DOI":"10.1016\/j.atherosclerosis.2007.04.055"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/1\/227\/2609775\/227.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/1\/227\/2609775\/227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T01:12:45Z","timestamp":1655428365000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/1\/227\/549538\/Epigenetic-Profiles-Distinguish-Pleural"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,31]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,12,31]]},"published-print":{"date-parts":[[2009,1,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-2586","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22376901","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376898","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376898.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22376901.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498363.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498363","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,31]]}}}